The largest database of trusted experimental protocols

Aia 2000

Manufactured by Tosoh
Sourced in Japan, United States

The AIA-2000 is an automated immunoassay analyzer developed by Tosoh. It is designed to perform a variety of immunoassay tests, including those for hormones, tumor markers, and infectious diseases. The AIA-2000 features automated sample handling, incubation, and data processing capabilities to provide accurate and efficient test results.

Automatically generated - may contain errors

10 protocols using aia 2000

1

Hyponatremia and Eosinophilia Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hyponatremia was defined as a serum sodium concentration lower than 135 mmol/L and eosinophilia as a count of not less than 500 eosinophils per microliter of blood. TSH was measured with enzyme immunoassay using ST AIA-PACK TSH (TOSOH, Ltd., Tokyo, Japan) on AIA-2000 (TOSOH, Ltd., Tokyo, Japan). FT4 was measured with fluorimetric enzyme-linked immunoassay using ST AIA-PACK FT4 (TOSOH, Ltd., Tokyo, Japan) on AIA-2000 (TOSOH, Ltd., Tokyo, Japan). Low TSH was defined as TSH value below the lower limit of the reference range (TSH reference range 0.38–4.31 μIU/mL) and low fT4 was defined as fT4 value below the lower limit of the reference range (fT4 reference range 0.82–1.63 ng/dL).
+ Open protocol
+ Expand
2

Assessing Menstrual Cycle Phases

Check if the same lab product or an alternative is used in the 5 most similar protocols
The beginning of the follicular phase was indicated by the onset of menses. To assess the menstrual cycle phase on experimental days ( 31 ), rectal temperature was recorded and venous blood samples were taken for measurement of sex hormones estrogen (17β-estradiol) and progesterone concentration. Rectal temperature was measured in the morning that is about 5-minute after awakening by each subject on the testing day using a thermocouple (Rectal Probe; Ellab, Hvidovre, Denmark; accuracy ±0.01° C) inserted to a depth of 12 cm past the anal sphincter. At the beginning of each experimental trial (Figure 1A), blood samples for estrogen (17βestradiol) and progesterone were collected by venipuncture in vacuum tubes for serum with gel separator (5 ml). Blood samples were allowed to clot and serums were separated by centrifugation (1,200g, 15 minutes) at room temperature. The serum samples were aliquotted and stored at -70° C until analysis. The automated enzyme immunoassay analyzer AIA-2000 (Tosoh Corporation, Tokyo, Japan) was used for blood analysis.
+ Open protocol
+ Expand
3

Comprehensive Metabolic Profiling of Participants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The baseline clinical features recorded included age, gender, body height (BH), body weight (BW), systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference, and prior history of comorbidities. Body mass index (BMI) was calculated as BW divided by the square of BH (kg/m2). Twenty milliliters of venous blood were collected after 12 h of fasting, and 5 mL of mid-stream urine was collected in the morning. Serum metabolic parameters, including glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), uric acid (UA), and creatinine (Cr) were measured using an automatic analyzer (Toshiba 7600, Japan). Fasting insulin (FINS) and fasting C-peptide (CP) were measured using a chemiluminescence analyzer (Tosoh AIA2000, Japan). HbA1c levels were measured with high-performance liquid chromatography (Tosoh G8, Japan). Urine ACR was measured using an automatic chemiluminescence immunoassay (BioSystems A25, Spain). We calculated homeostasis model assessment—insulin resistance (HOMA-IR) using the following formula [10 (link)]: FINS × FPG/22.5. Ccr was estimated using the Cockcroft–Gault formula in mL/min (for males, [140 − age (years)] × BW (kg)/72 × Cr (mg/dL); for females, [140 − age (year)] × BW (kg)/85 × Cr (mg/dL)).
+ Open protocol
+ Expand
4

Blood Sample Collection and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects had peripheral blood samples taken and drawn into vacutainers, which contained dipotassium ethylenediaminetetraacetic acid (K2EDTA) (BD Vacutainer®; Becton Dickinson UK Ltd., Wokingham, UK). Samples of the routine clinical chemistry assay were directly transported to the hospital laboratory. For the complete blood count test, the XE-5000 (Sysmex, Kobe, Japan) and UniCel® DxH 800 Coulter® Cellular Analysis System automated hematology analyzer (Beckman Coulter, Miami, FL, USA) were utilized. For the total IgE level test, the AIA-2000 automated immunoassay analyzer (Tosoh Bioscience, South San Francisco, CA, USA) was utilized.
+ Open protocol
+ Expand
5

Routine Clinical Chemistry Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each routine clinical chemistry test, investigated subjects’ blood samples were transported directly to our hospital laboratory. A complete blood count test was performed with an automated hematology analyzer UniCel® DxH 800 Coulter® Cellular Analysis System (Beckman Coulter, Miami, FL, USA), and immunoglobulin E (IgE) level was measured by automated immunoassay analyzer AIA-2000 (Tosoh Bioscience, South San Francisco, CA, USA).
+ Open protocol
+ Expand
6

Serum CEA and CA19.9 Biomarker Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum CEA and CA19.9 levels were determined in the Clinical Biochemistry Laboratory at MSKCC using a fluorometric enzyme immunoassay on the Tosoh AIA 2000 (Tosoh USA, Grove City, OH), as part of the patient’s clinical evaluation. Reference ranges for CEA (0–5 ng/ml) and CA19.9 (0–40 ng/ml) were established by the performing laboratory.
+ Open protocol
+ Expand
7

Serum CEA and CA19.9 Biomarker Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum CEA and CA19.9 levels were determined in the Clinical Biochemistry Laboratory at MSKCC using a fluorometric enzyme immunoassay on the Tosoh AIA 2000 (Tosoh USA, Grove City, OH), as part of the patient’s clinical evaluation. Reference ranges for CEA (0–5 ng/ml) and CA19.9 (0–40 ng/ml) were established by the performing laboratory.
+ Open protocol
+ Expand
8

Biomarker Assessment in Diabetes

Check if the same lab product or an alternative is used in the 5 most similar protocols
HbA1c, lipids, and serum creatinine were measured using UniCel DxC 800 Synchron system (Beckman Coulter, Brea, CA, USA). Normal cut-off values for HbA1c were 4–6% (20 mmol/mol–42 mmol/mol). Optimal metabolic control was defined as HbA1c below 7% (53 mmol/mol) without severe hypoglycemias as recommended by International Society for Pediatric and Adolescent Diabetes (ISPAD) [19 (link)]. Normal values for low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglycerides (Tg) were defined as <2.6 mmol/L, >1.1 mmol/L and <1.7 mmol/L, respectively. Normal values for total cholesterol (TCh) were <5.2 mmol/L for patients ≥16 years and <5.5 mmol/L for children under 16 years. At least one abnormal lipid level indicated dyslipidemia. Normal cut-off values for creatinine were 39–91 µmol/L. Cystatin C was measured by an automated enzyme immunoassay system AIA 2000 (TOSOH Corporation, Tokyo, Japan) with a normal range of 0.52–0.97 mg/L.
+ Open protocol
+ Expand
9

Chemiluminescence Tumor Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor markers were measured by chemiluminescence using the AIA2000 automatic chemiluminescence analyzer and corresponding reagents (TOSOH Co., Ltd., Tokyo, Japan). Calibrator was the original matched reagent. Internal quality control products were obtained from the Randox (lot 1:1575EC; lot 2:1578EC; Crumline, UK). All EQA samples were provided by the National Center for Clinical Laboratories (lots 201711, 201712, 201713, 201714, 201715).
+ Open protocol
+ Expand
10

Serum Cortisol and Troponin I Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were drawn by the standard venipuncture procedure for each study patient on admission. The samples were allowed to clot at room temperature, and the sera were separated for analyses. The serum concentrations of cortisol and troponin I were quantified by using commercially available kits (ST AIA-PACK CORT and ST AIA-PACK cTnI 3rd Gen, respectively) using the automated enzyme immunoassay analyzer AIA-2000 (Tosoh Corporation, Tokyo, Japan) while following the manufacturer recommendations. The normal value of cortisol was considered as 177–578 nmol/L at 7 a.m., and <434 nmol/L at 4 p.m.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!